Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2′,4′-difluorophenyl)-salicylanilide derivatives

Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2′,4′-difluorophenyl)-salicylanilide derivatives

US Patent 12478632 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tris DBA pharmaceutical composition and its use for treating autoimmune diseases2024
Tris DBA pharmaceutical composition and its use for treating autoimmune diseases2024
Diagnostic kits and methods configured to rapidly and non-invasively determine p2024
Diagnostic kits and methods configured to rapidly and non-invasively determine p2024
In vitro immune synapse system and method of in vitro evaluating immune response2023
External electromagnetic shielding device2022
RF testing apparatus, movable testing device thereof, and case module thereof2020
Use of ginsenoside M1 for inhibiting renal fibrosis2019
Use of ginsenoside M1 for inhibiting renal fibrosis2019
Use of ginsenoside M1 for treating IgA nephropathy2019
Use of ginsenoside M1 for treating IgA nephropathy2019
Use of ginsenoside M1 for treating lupus nephritis2017